Aldoxorubicin Improves PFS in Some Relapsed/Refractory Sarcomas

Aldoxorubicin yielded significantly better progression-free survival over investigator ’s choice of various chemotherapy options in patients with relapsed or refractory leiomyosarcoma and liposarcoma, according to updated results of a phase III trial.
Source: CancerNetwork - Category: Cancer & Oncology Authors: Tags: News Sarcoma Source Type: news